Abstract:Highlights • Jellein-I-Cys conjugated to gold nanoparticles (GNPs) enhances antibacterial, antibiofilm, and anticancer activities. • Jellein-I-Cys-GNPs showed significantly lower MIC and MBC values against MRSA compared to the free peptide. • Conjugated Jellein-I reduced biofilm metabolic activity by over 82 %, as well as inhibiting and removing biofilms. • Conjugated peptide maintained over 80 % viability in rat dermal fibroblast cells, indicating low cytotoxicity. • In metastatic melanoma cell assays, Jellein-I-Cys-GNPs showed greater anticancer effects than the free peptide. Antimicrobial peptides (AMPs) and their conjugation with nanoparticles hold promise for targeting Methicillin-resistant Staphylococcus aureus (MRSA). In this study, Jellein-I peptide, with a cysteine at the C-terminus, was conjugated to gold nanoparticles (GNPs) to enhance its antibacterial, antibiofilm, and anticancer activities. The GNPs were synthesized and then conjugated to Jellein-I, forming Jellein-I-Cys-GNPs. The nanoparticles were characterized using UV–visible spectroscopy, transmission electron microscopy (TEM), dynamic light scattering (DLS), and Fourier transform infrared (FTIR) spectroscopy. UV–visible spectroscopy, DLS, and TEM confirmed the formation of GNPs with an average size of 5.5 nm. The UV–visible spectroscopy and FTIR results indicated the presence of peptide functional groups on the surface of the GNPs. To assess antibacterial activity, minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) assays were performed against MRSA strains. The conjugated Jellein-I exhibited lower MIC and MBC values (94 μM) compared to the free peptide (512 μM) against both clinical and standard MRSA strains. Additionally, GNP-conjugated Jellein-I demonstrated antibiofilm activity, inhibiting and removing biofilms while reducing metabolic activity by more than 82 %, 44 %, and 72 %, respectively. Cell viability studies on rat dermal fibroblast (RDF) cells showed over 80 % viability across all treatment concentrations. Furthermore, a clonogenic assay on the metastatic melanoma cell line (A375) demonstrated that GNP-conjugated Jellein-I had significantly better anticancer effects than the free peptide, even at a concentration as low as 9 μM. Our findings suggest that the conjugation of Jellein-I-Cys to GNPs could be a promising formulation for enhancing the antibacterial, antibiofilm, and anticancer activities of peptides. Further in vivo studies may establish this new nanoformulation as a potential therapeutic candidate for MRSA infections and cancer treatment. Graphical abstract Download: Download high-res image (246KB) Download: Download full-size image

The effect of halogenation on the antimicrobial activity, antibiofilm activity, cytotoxicity and proteolytic stability of the antimicrobial peptide Jelleine-I.

An optimized analog of antimicrobial peptide Jelleine-1 shows enhanced antimicrobial activity against multidrug resistant P. aeruginosa and negligible toxicity in vitro and in vivo

Multiple action mechanism and in vivo antimicrobial efficacy of antimicrobial peptide Jelleine‐I

The Antimicrobial, Hemostatic, And Anti‐Adhesion Effects of A Peptide Hydrogel Constructed by The All‐D‐enantiomer of Antimicrobial Peptide Jelleine‐1

Detection of Allergen-IgE interaction in Allergic Children Through Combined Impedance and ROS Measurements

Effect of Stereochemistry, Chain Length and Sequence Pattern on Antimicrobial Properties of Short Synthetic Β-Sheet Forming Peptide Amphiphiles

Jellein-I-conjugated gold nanoparticles: Insights into the antibacterial, antibiofilm activities against MRSA, and anticancer properties

Optimized Antimicrobial Peptide Jelleine-I Derivative Br-J-I Inhibits Fusobacterium Nucleatum to Suppress Colorectal Cancer Progression

Effects of Hydrophobicity on Antimicrobial Activity, Selectivity, and Functional Mechanism of Guanidinium‐Functionalized Polymers

Design of an α-helical antimicrobial peptide with improved cell-selective and potent anti-biofilm activity

D-amino acid substitution enhances the stability of antimicrobial peptide polybia-CP

The effect of lipidation and glycosylation on short cationic antimicrobial peptides

Antibacterial mechanism of the novel antimicrobial peptide Jelleine-Ic and its efficacy in controlling Pseudomonas syringae pv. actinidiae in kiwifruit

Jelleine, a Family of Peptides Isolated from the Royal Jelly of the Honey Bees (Apis mellifera), as a Promising Prototype for New Medicines: A Narrative Review

Unexpected effect of halogenation on the water solubility of small organic compounds

Silver/chitosan-based Janus particles: Synthesis, characterization, and assessment of antimicrobial activity in vivo and vitro

Effects of Chain Length and Hydrophobicity/charge Ratio of AMP on Its Antimicrobial Activity

Antibiofilm Activities of Multiple Halogenated Pyrimidines Against Staphylococcus aureus

Novel antimicrobial peptide CPF-C1 analogs with superior stabilities and activities against multidrug-resistant bacteria

Synthesis and antibacterial properties of fluorinated biodegradable cationic polyesters

Enhancing the antibacterial property of chitosan through synergistic alkylation and chlorination